Happify Health Granted U.S. Patent for “Adherence Fidelity,” a Novel AI Algorithm That Drives Conversational Health Interventions Based on the Detection of Psychological Cues
Trained by Clinicians, the New IP Uses Machine Learning to Detect Psychological Gaps in Therapeutic AI Conversations and Then Guide Users Towards Maximized Adherence and Efficacy
NEW YORK–(BUSINESS WIRE)–Today, leading digital mental health platform, Happify Health, announced the issuance of a U.S. patent encompassing Adherence Fidelity, a novel algorithm that harnesses the power of AI by using conversational dialog management and natural language processing to detect when a user slips away from the intention of an activity and gently guides them to be more adherent.
Happify Health has incorporated Adherence Fidelity technology into their Digital AI Coach, Anna, to deliver behavioral interventions to users on the Happify platform. Using this novel technology, Anna listens to the existence of various psychological cues, and in turn responds by asking questions that guide the user towards maximized health outcomes, while also expressing curiosity and increasing engagement.
“Human alliance and connection has always been one of the cornerstones of various intervention disciplines, and that need for interconnection has been heightened during the COVID-19 crisis,” said Ran Zilca, Chief Artificial Intelligence Officer at Happify Health. “Our new patented Adherence Fidelity algorithm is designed to interact with Happify’s users in a way that exhibits curiosity and sensitivity, and guides the conversation dynamically to improve health outcomes. This design helps AI to establish deeper relationships with users while maximizing the benefits of our digital interventions.”
Anna was trained by a team of clinicians, psychotherapists, content creators, writers, data scientists, and research psychologists to implement Adherence Fidelity so that the behavioral interventions she delivers achieve the most psychological benefit for Happify’s users. This technology has a broader application impact on Happify Health’s vision to deliver intelligent AI-driven care, as Anna also has capabilities to be trained in delivering disease-specific clinical protocol.
The Adherence Fidelity technology has been developed by Happify Health’s joint team of data scientists and clinical psychologists, and is the subject matter of U.S. Patent No. 10,813,584, issued by the U.S. Patent and Trademark Office.
About Happify Health:
Happify Health is a LifeTech company that delivers digital therapeutics and innovative care delivery models to improve mental and physical health. Happify Health’s safe, effective digital tools use scientific research from positive psychology, CBT and mindfulness, combined with a gamified approach and leading-edge technology, to impact everyday lives. Happify Health’s clinically-validated platform provides global access to one of the most comprehensive, evidence-based intervention catalog that is available from science, resulting in better health and business outcomes for organizations. For more information, visit www.happifyhealth.com
Britta Franson, Director – PR & Communications at Happify Health